Chao-Feng Mu (Chaofeng Mu)

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Epidermal Growth Factor Receptor

Top Venues

Molecular pharmaceutics

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Long Zhang, Chao-Feng Mu, Tinghong Zhang, Yingying Wang, Yili Wang, Luhui Fan, Cong Liu, Hao Chen, Jianliang Shen, Kun Wei, Huaqiong Li
Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+ Breast Cancer. ACS applied materials & interfaces 12 (29) (2020)
Jiaoyang Tao, Weidong Fei, Hongxia Tang, Chaoqun Li, Chao-Feng Mu, Hongyue Zheng, Fanzhu Li, Zhihong Zhu
Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma. Molecular pharmaceutics 16 (2) (2019)
Jianliang Shen, Han-Cheon Kim, Joy Wolfram, Chao-Feng Mu, Wei Zhang, Haoran Liu, Yan Xie, Junhua Mai, Hang Zhang, Zhi Li, Maria Guevara, Zong-Wan Mao, Haifa Shen
A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer. Nano letters 17 (5) (2017)
Chao-Feng Mu, Yang Xiong, Xue Bai, Yun-Jie Sheng, Jiajun Cui
Codelivery of Ponatinib and SAR302503 by Active Bone-Targeted Polymeric Micelles for the Treatment of Therapy-Resistant Chronic Myeloid Leukemia. Molecular pharmaceutics 14 (1) (2016)